Skip to main content

Georgia Marie Beasley, MD, MHS

Assistant Professor of Surgery
Office: Dept of Surgery, Durham, NC 27710
Campus Mail: DUMC Erwin Rd, Durham, NC 27710

Education and Training

  • Surgical Oncology Fellow, Surgery, Ohio State University, 2015 - 2017
  • General Surgery Resident, Surgery, Duke University, 2008 - 2015
  • M.H.S., Duke University, 2012
  • M.D., Duke University School of Medicine, 2008
  • B.A., Duke University, 2001

Publications

McMahon, N., T. Y. Cheng, G. M. Beasley, I. Spasojevic, W. Petros, C. K. Augustine, P. Zipfel, J. C. Padussis, G. Sanders, and Douglas S. Tyler. “Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?” Ann Surg Oncol 16, no. 4 (April 2009): 953–61. https://doi.org/10.1245/s10434-008-0288-1.

Full Text

McMahon, Nicole, Douglas Tyler, and Georgia Beasley. “Isolated limb infusion with melphalan for the treatment of advanced nonmelanoma cutaneous malignancies.” In Journal of the American Academy of Dermatology, 60:AB139–AB139. MOSBY-ELSEVIER, 2009.

Scholars@Duke

Beasley, G. M., N. McMahon, G. Sanders, C. K. Augustine, P. Zipfel, J. Padussis, M. A. Selim, et al. “Targeting N-cadherin to Enhance Cytotoxicity of Melphalan in Regional Chemotherapy: Final Results of a Phase I Study of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients (pts) with Locally Advanced In-transit Malignant Melanoma.” In Annals of Surgical Oncology, 16:2–3. SPRINGER, 2009.

Scholars@Duke

Beasley, Georgia M., Lauren Kahn, and Douglas S. Tyler. “Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models.” Surg Oncol Clin N Am 17, no. 4 (October 2008): 731–viii. https://doi.org/10.1016/j.soc.2008.04.002.

Full Text

Beasley, Georgia M., Rebecca P. Petersen, Jin Yoo, Nicole McMahon, Thomas Aloia, William Petros, Gretchen Sanders, et al. “Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.” Ann Surg Oncol 15, no. 8 (August 2008): 2195–2205. https://doi.org/10.1245/s10434-008-9988-9.

Full Text

Beasley, G., N. McMahon, G. Sanders, P. Zipfel, C. Augustine, W. Petros, J. Padussis, et al. “A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma.” In Journal of Clinical Oncology, 26:9013–9013. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.9013.

Full Text

Beasley, G., R. Petersen, J. Yoo, T. Aloia, W. Petros, G. Sanders, C. Tsung, S. Pruitt, H. Seigler, and D. Tyler. “Isolated limb infusion for in-transit malignant melanoma of the extremity: A well tolerated but less effective alternative to hyperthermic isolated limb perfusion.” In Annals of Surgical Oncology, 15:3–3. SPRINGER, 2008.

Scholars@Duke

Pages